The mechanism of action of genes with high mutation frequency in cancer

Credit: CC0 Public Domain

After the p53 tumor suppressor gene, the genes most frequently found mutated in cancer are those encoding two proteins of the SWI/SNF chromatin remodeling complex. This complex's function is to 'accommodate' the histones that cover the DNA of the chromosomes so that the processes of transcription, DNA repair and replication or chromosome segregation can occur, as appropriate. A group from the University of Seville has demonstrated at CABIMER that the inactivation of BRG1, the factor responsible for the enzymatic activity of the SWI/SNF complexes, leads to high genetic instability, a characteristic common to the vast majority of tumors.

This study's most important contribution is that it deciphers the mechanism by which this occurs. The SWI/SNF complex is necessary for cells to resolve the conflicts that occur in when the transcription and replication machineries collide at the same site and hinder each other. If any part of the SWI/SNF complex is mutated, DNA is defective and chromosomal breaks occur, largely promoted by the accumulation of DNA-RNA hybrids at the sites where conflicts occur.

This work solves a significant problem in molecular and by providing the SWI/SNF complex with a new function, and opens the possibility that this chromatin remodeler may be a tumor suppressor and that DNA-RNA hybrids constitute an important source of tumourigenicity. The study is part of the ERC Advanced project by Andrés Aguilera, professor of genetics, and its main author is Dr. Aleix Bayona-Feliu, working for the Juan de la Cierva program, and is published in the prestigious journal Nature Genetics.

Explore further

New repair mechanism for DNA breaks

More information: Aleix Bayona-Feliu et al. The SWI/SNF chromatin remodeling complex helps resolve R-loop-mediated transcription–replication conflicts, Nature Genetics (2021). DOI: 10.1038/s41588-021-00867-2
Journal information: Nature Genetics

Citation: The mechanism of action of genes with high mutation frequency in cancer (2021, May 14) retrieved 18 June 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments